New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2020, WHO recommendation on routes of oxytocin administration for the prevention of postpartum haemorrhage after vaginal birth
View latest version (2020)Bibliographic Info
GuidelineWHO recommendations for the prevention and treatment of postpartum haemorrhage
Year of Publication2012
Issuing InstitutionWorld Health Organization
Recommendation
Status
Retired
Recommended in favor
Strong
Certainty of evidence
Moderate
Oxytocin (IV or IM) is the recommended uterotonic drug for the prevention of postpartum haemorrhage in caesarean section